What is Vertex Pharmaceuticals's fair value?

Vertex Pharmaceuticals (VRTX) reported fair value of $7.50B in Q1 2026.

How has Vertex Pharmaceuticals's fair value changed year-over-year?

Vertex Pharmaceuticals's fair value increased by 12.3% year-over-year, from $6.68B to $7.50B.

What is the long-term trend for Vertex Pharmaceuticals's fair value?

Over 5 years (2020 to 2025), Vertex Pharmaceuticals's fair value has grown at a 60.9% compound annual growth rate (CAGR), from $670.71M to $7.24B.

Other

Fair Value

Vertex Pharmaceuticals Fair Value increased by 3.7% to $7.50B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.3%, from $6.68B to $7.50B. Over 5 years (FY 2020 to FY 2025), Fair Value shows an upward trend with a 60.9% CAGR.

Analysis

StatementBalance Sheet Statement

SectionOther

First reportedQ2 2018

Last reportedQ1 2026

Metric ID: other_debtand_equity_securities_fair_value

Historical Data

20 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$644.32M	$685.19M	$729.90M	$638.00M	$551.20M	$599.20M	$386.70M	$2.21B	$2.44B	$2.52B	$3.35B	$5.39B	$5.61B	$5.99B	$6.65B	$6.68B	$7.06B	$7.07B	$7.24B	$7.50B
QoQ Change	—	+6.3%	+6.5%	-12.6%	-13.6%	+8.7%	-35.5%	+470.4%	+10.7%	+3.1%	+32.9%	+61.2%	+4.0%	+6.8%	+11.1%	+0.4%	+5.6%	+0.2%	+2.3%	+3.7%
YoY Change	—	—	—	—	-14.5%	-12.5%	-47.0%	+245.7%	+343.1%	+320.2%	+765.5%	+144.6%	+129.6%	+137.8%	+98.8%	+23.9%	+25.8%	+18.1%	+8.7%	+12.3%

Range$386.70M – $7.50B

CAGR+67.7%

Avg YoY Growth+137.5%

Median YoY Growth+62.3%

Current Streak13 quarters growth

Frequently Asked Questions

What is Vertex Pharmaceuticals's fair value?: Vertex Pharmaceuticals (VRTX) reported fair value of $7.50B in Q1 2026.
How has Vertex Pharmaceuticals's fair value changed year-over-year?: Vertex Pharmaceuticals's fair value increased by 12.3% year-over-year, from $6.68B to $7.50B.
What is the long-term trend for Vertex Pharmaceuticals's fair value?: Over 5 years (2020 to 2025), Vertex Pharmaceuticals's fair value has grown at a 60.9% compound annual growth rate (CAGR), from $670.71M to $7.24B.